BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 28073119)

  • 21.
    Ding B; Ji X; Sun X; Zhang T; Mu S
    Xenobiotica; 2020 Aug; 50(8):913-918. PubMed ID: 32026737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide).
    Bournique B; Lambert N; Boukaiba R; Martinet M
    Br J Clin Pharmacol; 2001 Jul; 52(1):53-63. PubMed ID: 11453890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes.
    Dong G; Zhou Y; Song X
    Pharm Biol; 2018 Dec; 56(1):620-625. PubMed ID: 31070542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
    Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
    Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of tubeimoside I on the activity of cytochrome P450 enzymes in human liver microsomes.
    Wang R; Zheng K; Liu Y; Ji S; Tang Y; Wang J; Jiang R
    Xenobiotica; 2024 Feb; 54(2):57-63. PubMed ID: 38166553
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Zhang X; Feng P; Gao X; Wang B; Gou C; Bian R
    Pharm Biol; 2020 Dec; 58(1):247-252. PubMed ID: 32223485
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of propofol on human hepatic microsomal cytochrome P450 activities.
    McKillop D; Wild MJ; Butters CJ; Simcock C
    Xenobiotica; 1998 Sep; 28(9):845-53. PubMed ID: 9764927
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Ji X; Ding B; Wu X; Liu F; Yang F
    Xenobiotica; 2021 Mar; 51(3):262-267. PubMed ID: 33115303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pogostone inhibits the activity of CYP3A4, 2C9, and 2E1
    Zhang G; Zhang Y; Ma X; Yang X; Cai Y; Yin W
    Pharm Biol; 2021 Dec; 59(1):532-536. PubMed ID: 33915070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1.
    Kharasch ED; Hankins DC; Jubert C; Thummel KE; Taraday JK
    Drug Metab Dispos; 1999 Jun; 27(6):717-23. PubMed ID: 10348802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anemarsaponin BII inhibits the activity of CYP3A4, 2D6, and 2E1 with human liver microsomes.
    Wang M; Jiang W; Zhou J; Xue X; Yin C
    Pharm Biol; 2020 Dec; 58(1):1064-1069. PubMed ID: 33103940
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Zhang C; Li Y; Yin C; Zheng J; Liu G
    Pharm Biol; 2021 Dec; 59(1):935-940. PubMed ID: 35294326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
    Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
    Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Azide inhibits human cytochrome P -4502E1, 1A2, and 3A4.
    Salmela KS; Tsyrlov IB; Lieber CS
    Alcohol Clin Exp Res; 2001 Feb; 25(2):253-60. PubMed ID: 11236840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes.
    Wei J; Zhang H; Zhao Q
    Pharm Biol; 2018 Dec; 56(1):363-367. PubMed ID: 30122094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro effects of tacrolimus on human cytochrome P450.
    Lecointre K; Furlan V; Taburet AM
    Fundam Clin Pharmacol; 2002 Dec; 16(6):455-60. PubMed ID: 12685503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro study on the effect of cornin on the activity of cytochrome P450 enzymes.
    Zhang Q; Qu Z; Zhou Y; Zhou J; Yang J; Li S; Xu Q; Zhou X
    BMC Complement Med Ther; 2021 May; 21(1):138. PubMed ID: 33966625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor.
    Lu P; Schrag ML; Slaughter DE; Raab CE; Shou M; Rodrigues AD
    Drug Metab Dispos; 2003 Nov; 31(11):1352-60. PubMed ID: 14570767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
    Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
    Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a method to determine cytochrome P450 1A2, 2C9, 2D6 and 3A4 activity sheep hepatic microsomes.
    McBride GM; Soo JY; Varcoe T; Morrison JL; Wiese MD
    J Pharmacol Toxicol Methods; 2020; 106():106934. PubMed ID: 33080390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.